Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Study: Targeted Vaccinations Remain The Best Way To Halt Epidemics

By European Commission, Joint Research Centre (JRC) | February 26, 2018

Amid growing concerns over the low uptake of flu shots in Europe, scientists from the Italian National Research Council and the JRC confirm that vaccinations remain the best way forward when it comes to stopping the spread of infectious diseases.

It’s an option that is nearly always more effective than either doing nothing or attempting to contain an outbreak through quarantine.

Under normal circumstances, the most effective way to prevent illness is to vaccinate according to national immunization schedules.

Widespread immunization programs in Europe have made previously deadly diseases such as smallpox and polio a thing of the past.

This study looked specifically at epidemic outbreaks.
They found that in such cases targeting carefully selected individuals with vaccination can be successful in containing the outbreak, even with only a relatively small number of individuals getting the relevant shot.

The scientists ran physics-based simulations on networks which sought to replicate the way individuals interact with one another in the real world, such as through the global air transportation network.

The simulations are simplified versions of computational frameworks commonly used to investigate the global spread of real-world epidemics, such as Severe Acute Respiratory Syndrome (SARS).

Nevertheless, they help understanding basic features of the more complicated and realistic models.

In the simulations, individuals correspond to ‘nodes’ that can transmit an infection through the links between them.

The scientists found that quarantining nodes after the outbreak of an epidemic very quickly becomes ineffective. Quite early on in a simulated outbreak, even the ‘do nothing’ (non-intervention) strategy becomes preferable to quarantine.

Targeted vaccination was found to be the best option in nearly all epidemic cases. The scientists used a vaccination strategy based on ‘optimal percolation’, which consists of finding the least set of nodes that, when removed from a network, can fragment it into small clusters.

The idea behind this approach is that fragmenting the network ensures infections are contained within small groups, hence preventing the occurrence of large outbreaks.

This might all seem like common sense, but preventive vaccination is not common practice for all illnesses and for some, vaccines do not yet exist.

The norovirus outbreak at this year’s Winter Olympic Games is an example where quarantine has been used as the option available to health officials.

Medical professionals have attempted to initially contain the outbreak by imposing quarantine on the hundreds of staff who were unlucky enough to catch the virus. Despite these measures, the illness is continuing to spread and has started to affect some of the athletes.

In recent years, physicists have made significant advances in the field of network immunization, developing increasingly efficient techniques to immunize a network by the ‘removal’ (vaccination) of a few nodes. This knowledge can help to support health policy as policymakers look to ensure increased global security against epidemics.

(Original Source: https://ec.europa.eu/jrc/en/news/prevention-better-cure-targeted-vaccination-halt-epidemics)


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE